Day 2 Assessment of Staphylococcal Scalded Skin Syndrome in a 2-Year-Old
On day 2 of SSSS, focus your assessment on progression of skin involvement, signs of systemic toxicity, fluid/electrolyte derangements, and secondary complications, as the disease typically peaks within 24-48 hours of onset. 1, 2
Critical Vital Signs and Systemic Assessment
- Temperature monitoring for persistent or worsening fever, which indicates ongoing toxin production or secondary infection 1, 3
- Heart rate and blood pressure to detect early sepsis or hypovolemia from extensive skin loss 3
- Oxygen saturation to identify respiratory compromise 1
- Urine output monitoring (should be >1 mL/kg/hr) to assess adequate fluid resuscitation and renal perfusion 3
- Mental status changes including confusion or lethargy, which may indicate sepsis or electrolyte abnormalities 1, 3
Skin Examination Specifics
- Document percentage of body surface area (BSA) involved using a Lund-Browder chart or body map to track progression or improvement 1
- Assess for new bullae formation or extension of existing lesions, particularly in friction zones (axillae, groin, neck) 2, 4
- Evaluate Nikolsky sign (lateral pressure causing skin sloughing) in perilesional areas to gauge disease activity 2
- Examine for areas of denuded dermis that are weeping, bleeding, or showing signs of secondary bacterial colonization 1, 5
- Assess skin pain level, as increasing pain may indicate secondary infection rather than improvement 1
- Look for periorificial crusting around eyes, nose, and mouth, which is characteristic of SSSS 2
Mucous Membrane Examination
- Confirm absence of mucosal involvement (oral, ocular, genital) to distinguish SSSS from toxic epidermal necrolysis, which requires different management 6, 1
- Check conjunctivae for inflammation without erosions (mild conjunctivitis may occur, but true mucosal erosions suggest TEN) 6
Laboratory Monitoring
- Complete blood count to assess for leukopenia (a frequent finding in severe SSSS) or leukocytosis suggesting secondary infection 3
- C-reactive protein to monitor inflammatory response and detect worsening infection 1, 3
- Serum sodium as hyponatremia is a common complication from fluid shifts and losses 3
- Renal function (BUN/creatinine) to detect acute kidney injury from hypovolemia 1, 3
- Liver function tests, glucose, magnesium, and phosphate as baseline and to guide supportive care 1
Fluid Balance Assessment
- Monitor for fluid overload, which is paradoxically more common than hypovolemia despite extensive skin loss 3
- Watch for signs of overhydration including peripheral edema, pulmonary crackles, or increasing oxygen requirements 3
- Calculate fluid balance (intake minus output) over the previous 24 hours 3
- Assess for dehydration signs including decreased skin turgor in unaffected areas, dry mucous membranes, and sunken fontanelle if still open 3, 4
Signs of Secondary Infection or Sepsis
- Increasing skin pain in denuded areas 1
- Purulent drainage from skin lesions 1
- Rising C-reactive protein or new-onset neutrophilia 1
- Hypotension or persistent tachycardia despite adequate fluid resuscitation 1
- Reduced oxygen saturation or increased work of breathing 1
Response to Antibiotic Therapy
- Evaluate for clinical improvement including cessation of new blister formation, which should occur within 24-48 hours of appropriate antibiotics 2, 7
- If no improvement after 24-48 hours on beta-lactam therapy, consider MRSA coverage with vancomycin or linezolid 8, 2, 7
- Review culture results from initial blood, skin lesions, and potential primary infection sites (nasopharynx, conjunctivae, umbilicus) to guide antibiotic adjustment 1, 2
Wound Care Assessment
- Examine dressing integrity and assess whether bland emollients and appropriate wound coverage are maintaining moisture balance 1, 5
- Check for adherent dressings causing trauma during changes 5
- Evaluate pain control adequacy during dressing changes and at rest 5
Common Pitfalls to Avoid
- Do not mistake fluid overload for inadequate resuscitation—SSSS patients frequently develop edema despite appropriate fluid management 3
- Do not assume improvement based solely on defervescence—assess skin progression and systemic markers 2
- Do not delay MRSA coverage in critically ill patients or those in high-prevalence communities 8, 2, 7
- Do not overlook hyponatremia and leukopenia, which are frequent laboratory findings requiring monitoring 3